#USA #Cleveland #Cleveland Clinic #IBM #RIKEN

Cleveland Clinic, RIKEN, and IBM: A Leap in Quantum Healthcare Innovation

In an impressive milestone for the merging fields of quantum computing and life sciences, a collaborative team from Cleveland Clinic, RIKEN, and IBM has been selected as finalists for the esteemed 2026 ACM Gordon Bell Prize. This recognition celebrates their innovative work in simulating protein structures using quantum computers, specifically focusing on a massive 12,635-atom complex.

The Value of Quantum in Drug Discovery

The journey towards this groundbreaking achievement began with a focused investigation into enhancing the computational methods for drug discovery. The core objectives involved two significant challenges: first, accurately modeling the dynamics of atoms during biological processes, and second, precisely calculating their energy configurations, particularly well-served by the unique capabilities of quantum computers, which leverage the laws of quantum mechanics.

Initially, the research was unveiled in May 2026, where the team made substantial strides in calculating the electronic structures of two large protein complexes using IBM Quantum Heron processors. These operations were facilitated by IBM's quantum computers at Cleveland Clinic and RIKEN, with computations running parallelly on some of the world's leading supercomputers—Fugaku, positioned at RIKEN, and the Miyabi-G, operated by the University of Tokyo and University of Tsukuba.

Unprecedented Scale and Accuracy

The scope of the computations involved utilizing up to 94 qubits to execute about 6,000 quantum operations, a feat that contributed immensely to their accuracy. By combining the expertise of classical computing with quantum approaches, the researchers demonstrated the first-ever simulation of a 303-atom protein shortly before scaling the method to cover larger molecular constructs, achieving an approximately 210 times improvement in computational accuracy.

This dual approach of conducting simulations on both quantum and classical platforms not only illustrates the innovative edge of their methodology but also paves the way for future advancements in the realm of quantum-centric supercomputing applicable to life sciences.

A Streamlined and Automated Workflow

Recent updates, especially a validation conducted on a third supercomputer, RIKEN's latest JHPC-quantum GPU 'ROQUO', further optimize the workflow by minimizing intricate manual processes and data transfers. This streamlined approach promotes a quicker and more efficient research environment. Orchestrating CPUs, GPUs, and QPUs collectively allows for dramatic reductions in errors and creates an avenue for real-time scientific progress.

The potential implications of this research are vast, significantly impacting the ability of researchers to predict how therapeutic agents interact with various biological targets at the molecular level, thereby accelerating the pathway to new drug discoveries.

The research team includes prominent figures such as Kenneth Merz Jr., Akhil Shajan, Danil Kaliakin, and various contributors from both Cleveland Clinic and RIKEN, emphasizing the strong collaborative efforts behind this extraordinary achievement.

Looking Ahead

As the announcement for the 2026 Gordon Bell Prize looms closer, expectations heighten over the capabilities that these advancements in quantum computing may unlock for healthcare and beyond. The amalgamation of quantum and classical methodologies not only showcases the significant strides being made but also marks a pivotal moment in the future of computational science. The progressive findings serve as a reminder of the limitless possibilities that lie at the intersection of medicine and innovative technology.

For more detailed insights, you can access the full study here.

• ---

About Cleveland Clinic: Cleveland Clinic operates as a global leader in healthcare with a commitment to integrating clinical and research practices established nearly a century ago.

About RIKEN: A prestigious research institution in Japan committed to exploring vast scientific domains, RIKEN develops tools such as the world-renowned Fugaku supercomputer.

About IBM: An industry trailblazer in cloud, AI, and quantum computing developments, IBM enhances business efficiencies with its cutting-edge solutions.